These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31362433)

  • 1. Mucin Thin Layers: A Model for Mucus-Covered Tissues.
    Rondelli V; Cola ED; Koutsioubas A; Alongi J; Ferruti P; Ranucci E; Brocca P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coarse-grained modeling of mucus barrier properties.
    Gniewek P; Kolinski A
    Biophys J; 2012 Jan; 102(2):195-200. PubMed ID: 22339855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undefined role of mucus as a barrier in ocular drug delivery.
    Ruponen M; Urtti A
    Eur J Pharm Biopharm; 2015 Oct; 96():442-6. PubMed ID: 25770770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A free-floating mucin layer to investigate the effect of the local microenvironment in lungs on mucin-nanoparticle interactions.
    Wan F; Herzberg M; Huang Z; Hassenkam T; Nielsen HM
    Acta Biomater; 2020 Mar; 104():115-123. PubMed ID: 31945503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.
    Kirkham S; Sheehan JK; Knight D; Richardson PS; Thornton DJ
    Biochem J; 2002 Feb; 361(Pt 3):537-46. PubMed ID: 11802783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoadhesion vs mucus permeability of thiolated chitosan polymers and their resulting nanoparticles using a quartz crystal microbalance with dissipation (QCM-D).
    Oh S; Borrós S
    Colloids Surf B Biointerfaces; 2016 Nov; 147():434-441. PubMed ID: 27568354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGSE-NMR and SANS studies of the interaction of model polymer therapeutics with mucin.
    Griffiths PC; Occhipinti P; Morris C; Heenan RK; King SM; Gumbleton M
    Biomacromolecules; 2010 Jan; 11(1):120-5. PubMed ID: 19950890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The properties of the mucus barrier, a unique gel--how can nanoparticles cross it?
    Pearson JP; Chater PI; Wilcox MD
    Ther Deliv; 2016; 7(4):229-44. PubMed ID: 27010985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods to determine the interactions of micro- and nanoparticles with mucus.
    Grießinger J; Dünnhaupt S; Cattoz B; Griffiths P; Oh S; Borrós i Gómez S; Wilcox M; Pearson J; Gumbleton M; Abdulkarim M; Pereira de Sousa I; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Oct; 96():464-76. PubMed ID: 25641005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal mucin: an adherent mucus gel barrier is absent in the normal esophagus but present in columnar-lined Barrett's esophagus.
    Dixon J; Strugala V; Griffin SM; Welfare MR; Dettmar PW; Allen A; Pearson JP
    Am J Gastroenterol; 2001 Sep; 96(9):2575-83. PubMed ID: 11569678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into bacterial recognition of intestinal mucins.
    Etzold S; Juge N
    Curr Opin Struct Biol; 2014 Oct; 28():23-31. PubMed ID: 25106027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucus as a barrier to lipophilic drugs.
    Sigurdsson HH; Kirch J; Lehr CM
    Int J Pharm; 2013 Aug; 453(1):56-64. PubMed ID: 23727593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of mucus on drug transport and its potential to affect therapeutic outcomes.
    Murgia X; Loretz B; Hartwig O; Hittinger M; Lehr CM
    Adv Drug Deliv Rev; 2018 Jan; 124():82-97. PubMed ID: 29106910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of the mucus barrier on the
    Dubaissi E; Rousseau K; Hughes GW; Ridley C; Grencis RK; Roberts IS; Thornton DJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):726-731. PubMed ID: 29311327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering.
    Griffiths PC; Cattoz B; Ibrahim MS; Anuonye JC
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):218-22. PubMed ID: 25986588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on mucus properties and formation--lessons from the biochemical world.
    Ambort D; Johansson ME; Gustafsson JK; Ermund A; Hansson GC
    Cold Spring Harb Perspect Med; 2012 Nov; 2(11):. PubMed ID: 23125206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucins: a biologically relevant glycan barrier in mucosal protection.
    Corfield AP
    Biochim Biophys Acta; 2015 Jan; 1850(1):236-52. PubMed ID: 24821013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin-based stationary phases as tool for the characterization of drug-mucus interaction.
    Gargano AF; Lämmerhofer M; Lönn H; Schoenmakers PJ; Leek T
    J Chromatogr A; 2014 Jul; 1351():70-81. PubMed ID: 24894112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport properties and aggregation phenomena of polyoxyethylene sorbitane monooleate (polysorbate 80) in pig gastrointestinal mucin and mucus.
    Lafitte G; Thuresson K; Jarwoll P; Nydén M
    Langmuir; 2007 Oct; 23(22):10933-9. PubMed ID: 17894509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic Acid Molecular Weight-Dependent Modulation of Mucin Nanostructure for Potential Mucosal Therapeutic Applications.
    Hansen IM; Ebbesen MF; Kaspersen L; Thomsen T; Bienk K; Cai Y; Malle BM; Howard KA
    Mol Pharm; 2017 Jul; 14(7):2359-2367. PubMed ID: 28499338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.